Menu Search
Equities

Clariane SE

KO2:BER

Clariane SE

Actions
Health CareHealth Care Providers
  • Price (EUR)3.37
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-57.34%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Clariane SE, formerly Korian SE, is a France-based company that operates healthcare facilities and medical establishments. The Company's holdings include residential centers for the elderly, offering permanent social care and medical support; follow-up care and rehabilitation centers, including general and specialized centers. Furthermore, the Company offers hospitalization at home, which avoids or shortens the hospitalization process; and home nursing services, which allows the care prescribes by a doctor at home. Korian-Medicas' establishments are located in France, Italy, Belgium and Germany via its subsidiaries, Segesta S.p.A., Phonix GmBH, Reacti Malt SAS, Sas La Normandie, Sa La Bastide de la tourne, Sas Mapadex La Roseraie, among others.

  • Revenue in EUR (TTM)5.00bn
  • Net income in EUR-92.44m
  • Incorporated2003
  • Employees61.25k
  • Location
    Clariane SE21 - 25 rue BalzacPARIS 75008FranceFRA
  • Phone+33 155375200
  • Fax+33 155375201
  • Websitehttps://www.korian.fr/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.